1 Min Read
Jan 26 (Reuters) - Santhera Pharmaceuticals Holding AG:
* SANTHERA RECEIVES NEGATIVE CHMP OPINION ON APPEAL FOR AUTHORIZATION OF RAXONE® IN DUCHENNE MUSCULAR DYSTROPHY Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.